Urgent.News

What's breaking now, across thousands of outlets.

World

TB Alliance fails to get patent for six-month treatment regimen

The Indian Patent Office on Tuesday rejected a patent application for BPaL, a combination of three medicines that has cut treatment for drug-resistant tuberculosis (TB) to six months, according to a joint statement by the groups that opposed it

TB Alliance fails to get patent for six-month treatment regimen

We haven't written up this one. Hindustan Times has the full story — the link below goes straight to it.

Read the original at hindustantimes.com →

More in World

More from Thursday 29 October →